Archive: 4 22 2025
EHA co-authors policy paper on drug repurposing
EHA has joined forces with other stakeholders such as the European Cancer Organisation, EORTC, and more, to author a policy paper on drug repurposing.
EHA updates its position on the EU pharmaceutical legislation
The European Union is currently revising its outdated pharmaceutical framework, with a new proposed Directive and Regulation under scrutiny.